HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Levels of asymmetrical dimethylarginine are predictive of brachial artery flow-mediated dilation 6 years later. The Cardiovascular Risk in Young Finns Study.

AbstractAIM:
Plasma asymmetric dimethylarginine (ADMA) is a novel risk factor for atherosclerosis and has been observed to associate with endothelial function in cross-section studies. In the present study our aim was to investigate whether plasma ADMA levels are predictive of brachial artery endothelial function in a prospective setting.
METHODS AND RESULTS:
Using ultrasound we measured brachial artery flow-mediated dilation (FMD) both in 2001 and 2007 in 1808 healthy subjects aged 24-39 years at baseline. Plasma methylarginines were determined by isocratic high-pressure liquid chromatography in 2001. In a multivariable model adjusted with brachial diameter and conventional cardiovascular risk factors, baseline ADMA levels had a significant inverse association with FMD measured 6 years later (β±SE: -1.89±0.69%, P=0.006).
CONCLUSIONS:
We conclude that plasma ADMA can predict brachial artery FMD in subjects without prevalent atherosclerotic disease. These data suggest that plasma ADMA may have a determinative role in predicting endothelial function.
AuthorsHannu Päivä, Mika Kähönen, Terho Lehtimäki, Georg Alfthan, Jorma Viikari, Reijo Laaksonen, Nina Hutri-Kähönen, Tomi Laitinen, Leena Taittonen, Olli T Raitakari, Markus Juonala
JournalAtherosclerosis (Atherosclerosis) Vol. 212 Issue 2 Pg. 512-5 (Oct 2010) ISSN: 1879-1484 [Electronic] Ireland
PMID20655043 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2010 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • N,N-dimethylarginine
  • Arginine
Topics
  • Adult
  • Arginine (analogs & derivatives, biosynthesis)
  • Brachial Artery (pathology)
  • Cardiovascular Diseases (diagnosis, epidemiology)
  • Chromatography, High Pressure Liquid (methods)
  • Cohort Studies
  • Endothelium, Vascular (cytology)
  • Female
  • Finland
  • Humans
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: